Qingyan Gao, Li Zhang, Xin Zhao, Yangmin Zhu, Guangxin Peng, Yang Li, Yuan Li, Jianping Li, Lin Song, Lei Ye, Huihui Fan, Kang Zhou, Wenrui Yang, Yang Yang, Liping Jing, Fengkui Zhang
Objective : Eltrombopag monotherapy or eltrombopag combined with immunosuppressant has achieved robust hematologic responses in severe aplastic anemia (SAA). In patients with refractory SAA, for whom hematopoietic stem cell transplantation is unavailable, we attempted to combine eltrombopag with oral immunosuppressant and androgen, to further improve hematologic response. Methods : We collected and analyzed data retrospectively from twelve refractory SAA cases who had received combination therapy of eltrombopag, oral immunosuppressant and androgen...
December 2020: Hematology (Amsterdam, Netherlands)